Medical Xpress·3 min read·medium

Ivermectin taken at the start of pregnancy is not associated with an increased risk of adverse pregnancy outcomes

B
Barcelona Institute for Global Health
Ivermectin taken at the start of pregnancy is not associated with an increased risk of adverse pregnancy outcomes
AI Summary

A study conducted by the Barcelona Institute for Global Health found no increased risk of adverse pregnancy outcomes for women inadvertently exposed to ivermectin during early pregnancy. While the findings suggest safety, researchers note the sample size is too small to change current medical recommendations.

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealth

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in